Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Cell-Based Assays Global Market estimated to be worth $20.1 billion by 2025The demand for cost effective alternatives for animal testing and increasing approval of biologics and biosimilars is driving the growth of cell-based assays global market.
According to IQ4I analysis, the Cell-based assays global market is estimated to grow at high single digit CAGR to reach $20.1 billion by 2025. The factors driving the market are rising use of the cell-based assays in drug discovery and development, increasing focus on biologics, technological advancements (platforms for High Throughput Screening (HTS), High-content screening (HCS), novel microscopy-based technologies, increased automation in liquid handling instruments, and advanced software for automation and data acquisition and analysis) favoring the adoption of Cell-based assays, the rise in availability of funds for research. Whereas, factors such as lack of skilled professionals, ethical concerns over the use of raw materials from animal sources, high cost of instruments, lack of standardization, consistency and reproducibility issues are restraining the market growth. The report covers business intelligence information such as, Product and service costs (Assay kits, instruments and cell line), Key market developments (acquisitions, collaborations and expansions), Services capabilities matrix (drug discovery, development, and manufacturing) Some of the key players in Cell-based assays market are Danaher (U.S.) For more details please visit our website or contact: Mr. Satish Birudukota, Website: https://www.iq4i.com/ Email: bd@iq4i.com, satish.birudukota@ Phone: +91-9886722024, 8147030229, End
Account Phone Number Disclaimer Report Abuse
|
|